A research team from Trinity College Dublin has unveiled a new approach to vaccination that could redefine how we protect against respiratory infections. In a study published in Nature Microbiology, the team demonstrate that their nasally delivered, antibiotic-inactivated Bordetella pertussis (AIBP) vaccine not only prevents severe disease but also curbs bacterial transmission—an achievement long sought by vaccine developers worldwide.
New nasal vaccine has potential to transform respiratory disease prevention
